MedPath

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

Phase 3
Terminated
Conditions
Onychomycosis
Interventions
Drug: Placebo control
Registration Number
NCT01208129
Lead Sponsor
Promius Pharma, LLC
Brief Summary

The objectives of this study are to assess the safety of NAB001 for topical treatment of mild to moderate distal onychomycosis of the toenails over 52 weeks and to compare the efficacy of NAB001 to vehicle alone at the end of the study (Week 56) after treating for 52 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
458
Inclusion Criteria
  • mild to moderate fungal infection of the toenail as assessed by study doctor
  • koh positive & dermatophyte culture positive at Visit 1
  • general good health as assessed by study doctor
Exclusion Criteria
  • severe fungal toenail infection
  • prior use of antifungal drugs (wash-out allowed, duration varies on class)
  • significant confounding conditions as assessed by study doctor
  • pregnancy/lactation
  • must forego nail salon procedures during study for at least ~60 weeks

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active drugNAB001-
Vehicle alonePlacebo control-
Primary Outcome Measures
NameTimeMethod
Complete cure rate at Week 56. Complete cure defined as clinically clear nail and mycological cure.Week 56 after 52 weeks of treatment
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects with effective treatment at week 56. Effective treatment defined as mycological cure and an IGA of 0 or 1 (clear or almost clear).Week 56

Trial Locations

Locations (23)

North Florida Dermatology Association

🇺🇸

Jacksonville, Florida, United States

Associated Foot & Ankle Specialists, LLC

🇺🇸

Phoenix, Arkansas, United States

Radiant Research, Inc.

🇺🇸

Greer, South Carolina, United States

Family Foot Health Center

🇺🇸

Rogers, Arkansas, United States

Center for Dermatology Clinical Research, Inc.

🇺🇸

Fremont, California, United States

UCSF Dermatology Research

🇺🇸

San Francisco, California, United States

Avail Clinical Research

🇺🇸

DeLand, Florida, United States

Altus Research

🇺🇸

Lake Worth, Florida, United States

Park Avenue Dermatology

🇺🇸

Orange Park, Florida, United States

Lake Washington Foot and Ankle Center

🇺🇸

Melbourne, Florida, United States

Deaconess Clinic Downtown

🇺🇸

Evansville, Indiana, United States

Michigan Center for Skin Care Research

🇺🇸

Clinton Township, Michigan, United States

Department of Veteran's Affairs

🇺🇸

Minneapolis, Minnesota, United States

The Skin Wellness Center, PC

🇺🇸

Knoxville, Tennessee, United States

Pinkas Lebovits

🇺🇸

New York, New York, United States

Research Across America

🇺🇸

Plano, Texas, United States

Dermatology Research Center

🇺🇸

Salt Lake City, Utah, United States

Care Plus Podiatry, PC

🇺🇸

Wading River, New York, United States

Oregon Medical Research Center, PC

🇺🇸

Portland, Oregon, United States

Endeavor Clinical Trials

🇺🇸

San Antonio, Texas, United States

Madison Skin and Research, Inc.

🇺🇸

Madison, Wisconsin, United States

Coastal Podiatry, Inc.

🇺🇸

Virginia Beach, Virginia, United States

Skin Search of Rochester, Inc.

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath